(Research Triangle Park, N.C.) Mustard Tree Instruments®, continuing to lead the way in developing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges, announced today that CEO Todd Blonshine will be presenting on quality control issues at Pittcon 2012 in Orlando, Fla. on Sunday, March 11. Blonshine will be the first speaker participating in the High-Throughput Chemical Analysis session track beginning at 1:00 p.m., discussing an emerging multi-variant approach to obtaining immediate, unambiguous results from drug product samples using a combination of machine vision and Raman spectroscopy. (more…)

(Research Triangle Park, N.C.) Mustard Tree Instruments®, an innovator in analytical instrumentation for the pharmaceutical manufacturing industry, is pleased to announce that Science Officer Brisco Harward Ph.D. addressed members of the NY Section of the Society for Applied Spectroscopy (NYSAS) on November 9, 2011. Dr. Harward was invited to address the group by a leading spectroscopist who was attending a demonstration of the Mustard Tree Verifier™ Tri-Test 1000 (VTT-1000) analytical testing device earlier this fall. (more…)

(Research Triangle Park, N.C.) Catalent scientist and manager of Viral Clearance and Safety, Hazel Aranha, Ph.D., will have a prominent role in leading this year’s Viral Safety for Biologicals workshop held at the Angelo Hotel in Prague, Czech Republic on May 10-11, 2011. Sponsored by Informa Life Sciences, the annual workshop will provide attendees the ability to meet evolving regulatory requirements by learning the latest detection methods and how to react effectively when faced with the risk of viral contamination. (more…)

(Somerset, N.J.) Catalent Pharma Solutions, a leading provider of pharmaceutical services from drug and biologic development to delivery technologies to supply solutions, has announced three new appointments to its Development and Clinical Services business unit. Paul Wituschek has joined as the Vice President of Sales for the Development and Clinical Services business unit. Sven Lee will lead the Biologics sales team as the Vice President of Business Development. Dr. Paul Ingram is appointed to the newly created role of European Sales Director for Clinical Supply Services. Catalent is continuing to invest in building strong customer focus through the addition of these three sales veterans with outstanding, specialized industry experience. (more…)

(Research Triangle Park, N.C.) Carolyn Finkle, Vice President of Regulatory Consulting for North America at Catalent Pharma Solutions will have a leading role in this year’s Pharmaceutical Education and Research Institute (PERI) by teaching a spring and fall course on drug development. The spring course is entitled, “Basic Drug Development: From Molecule to Market” and will be held at the PERI training facility located in Arlington, VA on March 14 to March 15, 2011 from 8 a.m. to 5 p.m. on each day. (more…)

(Research Triangle Park, N.C.) Alan Hendricker, Ph.D., Principal Scientist of Structural Chemistry, and Thomas Feinberg, Ph.D., Director of Structural Chemistry, at Catalent Pharma Solutions will have prominent roles at this year’s PQRI workshop entitled “Thresholds and Best Practices for Parenteral and Ophthalmic Drug Products (PODP).” The workshop will be held at the Hyatt Regency in Bethesda, MD on February 22-23, 2011. (more…)

(Washington, D.C.) The Biotechnology Industry Organization (BIO) today announced the Business Roundtable series for the 13th Annual BIO CEO & Investor Conference – the world’s largest independent investor conference focused on publicly-traded biotechnology companies. This conference provides a forum for institutional investors, research analysts and senior industry executives to discuss investment trends, attend company presentations, conduct one-on-one meetings, and learn about investment opportunities within the biotechnology industry. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions announces the installation of electronic verification applications at its Clinical Supply Services facilities in Philadelphia, PA and Schorndorf, Germany. The addition of these automated process check stations is part of an ongoing investment to reduce customer costs and proactively increase service quality standards to better meet clinical trial needs globally. (more…)

(Research Triangle Park, N.C. Two Catalent scientists, Dr. Lei Mao, Project Director, Senior Scientist in the Pulmonary and Nasal Research and Development, and Dr. Craig J. Davies-Cutting, Director, Research and Development, will have prominent roles leading this year’s Drug Delivery to the Lungs 21 (DDL21) conference. The meeting will be held at the Edinburgh International Conference Centre in Edinburgh, Scotland, UK on December 8-10, 2010. (more…)